Citigroup Maintains Buy on Adient, Lowers Price Target to $29
Citigroup analyst Michael Ward maintains Adient (NYSE: ADNT ) with a Buy and lowers the price target from $33 to $29.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.